Purchases and Sales Made in Q1 2023 in Virax Biolabs Group LTD (VRAX)
This table provides information about the institutional ownership of Virax Biolabs Group LTD (VRAX) during Q1 2023. The information is specifically focused on institutions that hold shares of Virax Biolabs Group Ltd.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
1.5MNew |
$960K - $1.82M
|
1.5M
$2.96M
|
|
May 15, 2023
Q1 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
24.8KNew |
$15.9K - $30K
|
24.8K
$48.8K
|
|
May 12, 2023
Q1 2023
|
Hrt Financial LP
New York, NY |
BUY
|
- |
15.6KNew |
$10K - $18.9K
|
15.6K
$30.8K
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-2.85K- 2.77% |
$1.82K - $3.44K
|
99.8K
$197K
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-3.11K- 50.35% |
$1.99K - $3.77K
|
3.07K
$6.05K
|
|
Mar 29, 2024
Q1 2023
|
Kapitalo Investimentos Ltda
Sao Paulo, D5 |
SELL
|
- |
-118KClosed |
$75.2K - $142K
|
0
$0
|